Mutation Testing in Advanced Thyroid Cancer

All patients with advanced thyroid disease and most patients with incurable radioiodine refractory differentiated thyroid cancer should undergo somatic mutational testing, say experts.

Related Keywords

United States ,American ,David Shonka ,International Thyroid Oncology Group ,Neck Society Endocrine Surgery Section ,University Of Virginia ,Drug Administration ,American Head ,Thyroid Cancer ,Thyroid Carcinoma ,Ancer Of The Thyroid ,Malignant Head And Neck Neoplasm ,Medullary Thyroid Carcinoma ,Edullary Carcinoma Of The Thyroid ,Thyroid Disorder ,Anaplastic Thyroid Carcinoma ,Naplastic Carcinoma Of The Thyroid ,Chemotherapy ,Radiation Oncology ,Refractory ,Surgery ,Biologic Therapy ,Dna Sequencing ,Head And Neck Surgery ,Otolaryngology ,Nt Ears ,Nose ,Throat ,Precision Medicin ,